Some Polyphenolic Compounds as Potential Therapeutic Agents in Cervical Cancer: The Most Recent Advances and Future

Nazlı Tunca Sanlier1, Koray Görkem Saçinti2,3, İnci Türkoğlu4

  • 1Department of Obstetrics and Gynecology, Turkish Ministry of Health, Ankara City Hospital, Ankara 06800, Turkey.

Nutrition Reviews
|September 16, 2024
PubMed

Insights

Polyphenols, natural compounds found in food, show promise in cancer treatment by regulating cellular mechanisms. Studies indicate their safety and potential to impact cervical cancer incidence and management.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Cancer development involves genetic and cellular pathway disruptions.
  • Polyphenols from dietary sources exhibit anticancer properties.
  • Research is exploring polyphenols' role in cancer chemoprevention and treatment.

Purpose of the Study:

  • To review the properties and anticancer mechanisms of polyphenols.
  • To examine the potential of polyphenols in cervical cancer management.
  • To establish a foundation for further research into polyphenol applications for cervical cancer.

Main Methods:

  • Literature review of studies on polyphenol properties and activities.
  • Analysis of molecular mechanisms of polyphenols in cellular processes.
  • Examination of data from animal, cell, and human studies.

Main Results:

  • Polyphenols influence inflammation, cell proliferation, apoptosis, and epigenetic alterations.
  • Evidence suggests polyphenols are safe and well-tolerated.
  • Polyphenols demonstrate potential in ameliorating cancer biomarkers.

Conclusions:

  • Polyphenols possess significant potential for cancer treatment due to their safety, cost-effectiveness, and accessibility.
  • Further investigation into polyphenols' role in cervical cancer is warranted.
  • Polyphenols may offer a valuable complementary approach in cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K